FREMONT, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Protein Design Labs, Inc. (PDL) today announced that its financial results for the third quarter ended September 30, 2005 will be released following the close of the U.S. financial markets on Tuesday, November 1, 2005. PDL will hold a conference call to discuss these results, the status of its clinical development programs, its forward-looking information and guidance with respect to future results at 4:30 p.m. Eastern time on November 1, 2005. The call will be hosted by Mr. Mark McDade, Chief Executive Officer, Mr. Glen Y. Sato, Senior Vice President and Chief Financial Officer, and Dr. Steven Benner, Senior Vice President and Chief Medical Officer.
The live webcast will be available through the PDL website: www.pdl.com. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. Financial and statistical information to be discussed in the call will be available on the PDL website immediately prior to the commencement of the call. A replay will be available at www.pdl.com starting approximately one hour after completion of the webcast.
An audio replay will also be available by telephone from approximately 6:30 p.m. Eastern time on November 1, 2005 through 6:30 p.m. Eastern time on November 6, 2005. To access the replay, dial 800-633-8284 from inside the United States and 402-977-9140 from outside the United States; enter conference ID number 21266718.
PDL is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. Further information on PDL is available at www.pdl.com.
NOTE: Protein Design Labs and the PDL logo are registered U.S. trademarks of Protein Design Labs, Inc.
Protein Design Labs, Inc.
CONTACT: James R. Goff, Senior Director, Investor Relations of ProteinDesign Labs, +1-510-574-1421, or jgoff@pdl.com
Web site: http://www.pdl.com//
